Cargando…
Horizons in cancer research. Volume 67 /
| Clasificación: | Libro Electrónico |
|---|---|
| Otros Autores: | |
| Formato: | Electrónico eBook |
| Idioma: | Inglés |
| Publicado: |
New York :
Nova Science Publishers, Inc.,
[2017]
|
| Temas: | |
| Acceso en línea: | Texto completo |
Tabla de Contenidos:
- Preface; Chapter 1; miRNA as a Novel Diagnostic and Predictive Biomarker in Human Cancers; 1. Introduction; 1.1. miRNA as Gene Regulator; 1.1.1. Down-Regulation of Gene by miRNA; 1.1.2. miRNA Mediated Upregulation of Gene; 1.2. miRNA Biogenesis; 1.3. Different miRNA Families and Their Functions; 1.3.1. miRNA-200 Family; 1.3.2. Let-7 Family; 1.3.3. miR-34 Family; 1.3.4. miR-126 and miR-335; 1.3.5. miR-10b; 1.3.6. miR-21; 1.3.7. miR-373 and miR-520c; 1.3.8. miR-199/214 Family; 1.3.9. miR-92a; 1.3.10. miR-100; 1.4. miRNA Associated with Carcinogenesis
- 2. miRNA Associated with Gynecological Malignancies2.1. miRNA in Ovarian Cancer; 2.2. miRNA in Endometrial Cancer; 2.3. miRNA in Cervical Cancer; 2.4. miRNA in Vulvar Cancer; 3. miRNA as Diagnostic and Predictive Biomarker in Cancer; 3.1. miRNA in Ovarian Cancer Prediction; 3.2. miRNA in Breast Cancer Prediction; 4. Advantages of miRNA as an Epigenetic Marker in Cancer Diagnostics; Conclusion; References; Chapter 2; The Deregulated Expression and Function of S100 Proteins in Cancer Cells; Abstract; Introduction; Genes for S100 Proteins and Structure of S100 Proteins
- Functions of S100 ProteinsThe Role of the S100 Proteins in Metastatic Growth; Role of S100A8 and S100A9 in Pathogenesis of Myelodysplastic Syndrome with Deletion on Long Arm of Chromosome 5; Role of S100A8 and S100A9 in MDS; Inhibition of S100 Proteins; Conclusions and Perspectives; Acknowledgments; References; Chapter 3; Recent Perspectives in the Management of Nasopharyngeal Carcinoma; Abstract; 1. Introduction; 2. Staging; 3. Early-Stage Disease; 4. Locoregionally Advanced Nasopharyngeal Carcinoma; 4.1. Concurrent Chemoradiation
- 4.2. Induction Chemotherapy plus Concurrent Chemoradiotherapy4.3. Inhibition of EGFR (Cetuximab) in Combination with Chemoradiation; 5. Local Residual Nasopharyngeal Disease; 6. Recurrent and Metastatic Disease; 6.1. Surgery; 6.2. Radiation; 6.3. Chemotherapy; 6.4. Molecular-Targeted Therapies; 6.5. Therapeutic Vaccine Targeting Epstein-Barr Virus (EBV); 7. Evolution; Conclusion; References; Chapter 4; The State-of-the-Art Therapeutic Human Papillomavirus Vaccine; Abstract; Introduction; Historical Notes: From Pap Test to Vaccines; HPV Molecular Biology and Virology
- HPV Immunology and VaccinesConclusion; References; Index; Blank Page